GovChime

Department of Education Small Business Innovation Research (SBIR) Special Education Phase I 2021

Overview

Response deadline
11:00 AM UTC−05:00
Posted
May 17, 2021
Notice type
Presolicitation
Set-aside
Total Small Business Set-Aside (FAR 19.5)

Notice details

Office
CONTRACTS AND ACQUISTIONS MANAGEMEN
Last updated
Sep 9, 2025

Identifiers

Solicitation number
91990021R0002
Notice ID
c4481606307d4af092e40ca7b2291fe1

Description

The U.S. Department of Education (Department) anticipates the release of the 2021 Small Business Innovation Research Program (SBIR) Phase I solicitation on or about December 1, 2020. The purpose of the SBIR program is to stimulate technological innovation in the private sector, strengthen the role of small business in meeting Department research and development needs, increase the commercial potential of Department-supported research results, and improve the return on investment from Federally-funded research for economic and social benefits to the Nation. Phase I is to determine, insofar as possible, the scientific or technical merit of ideas submitted under the SBIR program. The proposal should concentrate on Research/Research & Development (R/R&D) that will establish the feasibility of the technological approach, a prerequisite for further Department support in Phase II. Awards are for periods up to 8-months in amounts up to $200,000. Firms with strong R/R&D capabilities for education technology products for use in Special Education in the priority areas listed are encouraged to participate. The 2021 priority areas consist of either: 1. Products to support infants, toddlers or learners with, or at risk for, disabilities, or educators (or other instructional personnel, related services providers, or family members); or 2. Products to prepare existing special education interventions with evidence to be used at scale in education settings. Products must fall in one of these priority areas (not all). Interested parties should continue to monitor this posting for updates. For more information about the Departments SBIR program, please see here: www.ies.ed.gov/sbir Note!! This posting is specifically for products for use in Special Education. For products to be used in standard education, please see the Notice for 91990021R0001. THIS IS A REQUEST FOR PROPOSALS (RFP). Please view the attachment for the complete RFP. Interested parties are reminded to continue to monitor this posting for updates. Amendment 0001 corrects the number of anticipated awards resulting from this solicitation from 15 awards to 5 awards. Additional clarification language is also included. All updates are provided in tracked changes. Amendment 0002 provides Government responses to timely questions received. Amendment 0003 provides updated budget instructions. Award has been made to the following successful offerors: Alchemie Soterix Medical 950 Stephenson Highway Suite 210 237 West 35th Street Suite 1401 Troy, MI 48083 New York, NY 10001 DUNS: 054577584 DUNS: 965459519 Contract #: 91990021C0031 Contract #:91990021C0032 Dollar Amount: $200,000.00 Dollar Amount: $200,000.00 Interested offerors are reminded that the Department will again participate in the SBIR program in 2022. Please expect preliminary information regarding the FY2022 requirement to be posted to Contract Opportunities in November 2021. Thank you.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:91990021R0002
  1. Pre-Solicitation

Formal solicitation typically follows within 30–60 days. (estimate)

  1. 6×
    Pre-SolicitationCurrentNov 10, 2020

    Department of Education Small Business Innovation Research (SBIR) Special Education Phase I 2021

    Notice c4481606307d4af092e40ca7b2291fe1 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

91990021R0002

Archive Date

Aug 1, 2021

Office Address

WASHINGTON, DC, 20202